Clinical trial studies help doctors and researchers find better ways to prevent, treat or diagnose diseases. There are several types of cancer clinical trials — some test new ways to treat cancer; others test new methods of prevention, detection or diagnosis.
Clinical trials follow a plan known as a protocol. The protocol is carefully designed to balance the potential benefits and risks to participants and answer specific research questions. A protocol describes the following:
Clinical trials are conducted in phases. The trials at each phase have a different purpose and help scientists answer different questions.
Current trials offered at Hunterdon Regional Cancer Center include new treatment protocols conducted by pharmaceutical companies and The National Institute of Health (Cooperative Group Trials).
Current trials may include treatment options for breast, colon, prostate or lung cancers, as well as, treatment options for gynecological, leukemia, lymphomas, melanoma, and hematologic conditions.
Please also see Cancer Clinical Trials at HHO for additional clinical trials.
To learn more about participation in current clinical trials with Hunterdon Regional Cancer Center, please contact Deborah Brunetti, Clinical Research Coordinator, at 908-237-2330 ext. 3 or visit Hunterdon Hematology Oncology.
Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma
Please see the website for further information.
Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation
Please see the website for further information.
Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE Trial
Please see the website for further information.
Hunterdon Regional Cancer Center
2100 Wescott Drive
Flemington, NJ 08822
United States